Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Sorbi, Sandro"" wg kryterium: Autor


Tytuł:
Putative novel CSF biomarkers of Alzheimer's disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort.
Autorzy:
Bigi A; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Section of Biochemistry, University of Florence, Viale Morgagni 50, 50134, Florence, Italy.
Fani G; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Section of Biochemistry, University of Florence, Viale Morgagni 50, 50134, Florence, Italy.
Bessi V; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Napolitano L; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Section of Biochemistry, University of Florence, Viale Morgagni 50, 50134, Florence, Italy.
Bagnoli S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Ingannato A; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Neri L; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Section of Biochemistry, University of Florence, Viale Morgagni 50, 50134, Florence, Italy.
Cascella R; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Section of Biochemistry, University of Florence, Viale Morgagni 50, 50134, Florence, Italy.
Matteini P; Institute of Applied Physics 'Nello Carrara', National Research Council, 50019, Sesto Fiorentino, Italy.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Nacmias B; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Cecchi C; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Section of Biochemistry, University of Florence, Viale Morgagni 50, 50134, Florence, Italy. .
Chiti F; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Section of Biochemistry, University of Florence, Viale Morgagni 50, 50134, Florence, Italy. .
Pokaż więcej
Źródło:
Translational neurodegeneration [Transl Neurodegener] 2024 Mar 08; Vol. 13 (1), pp. 14. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Letter
MeSH Terms:
Alzheimer Disease*/diagnosis
Humans ; Amyloid beta-Peptides ; tau Proteins ; Biomarkers
Opinia redakcyjna
Tytuł:
Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis.
Autorzy:
Pomeshchik Y; iPSC Laboratory for CNS Disease Modelling, Department of Experimental Medical Science, BMC D10, Lund University, 22184, Lund, Sweden. .; Strategic Research Area MultiPark, Lund University, 22184, Lund, Sweden. .; Lund Stem Cell Center, Lund University, 22184, Lund, Sweden. .
Velasquez E; iPSC Laboratory for CNS Disease Modelling, Department of Experimental Medical Science, BMC D10, Lund University, 22184, Lund, Sweden.; Strategic Research Area MultiPark, Lund University, 22184, Lund, Sweden.; Lund Stem Cell Center, Lund University, 22184, Lund, Sweden.
Gil J; Clinical Protein Science & Imaging, Department of Biomedical Engineering, BMC D13, Lund University, 22184, Lund, Sweden.
Klementieva O; Strategic Research Area MultiPark, Lund University, 22184, Lund, Sweden.; Medical Micro-Spectroscopy, Department of Experimental Medical Science, BMC B10, Lund University, 22184, Lund, Sweden.
Gidlöf R; Lund University BioImaging Centre, Faculty of Medicine, Lund University, 22142, Lund, Sweden.
Sydoff M; Lund University BioImaging Centre, Faculty of Medicine, Lund University, 22142, Lund, Sweden.
Bagnoli S; Laboratorio Di Neurogenetica, Dipartimento Di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino- NEUROFARBA, Università degli Studi di Firenze, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Nacmias B; Laboratorio Di Neurogenetica, Dipartimento Di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino- NEUROFARBA, Università degli Studi di Firenze, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Sorbi S; Laboratorio Di Neurogenetica, Dipartimento Di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino- NEUROFARBA, Università degli Studi di Firenze, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Westergren-Thorsson G; Department of Experimental Medical Science, BMC C12, Faculty of Medicine, Lund University, 22142, Lund, Sweden.
Gouras GK; Strategic Research Area MultiPark, Lund University, 22184, Lund, Sweden.; Experimental Dementia Research Unit, Department of Experimental Medical Science, BMC B11, Lund University, 22184, Lund, Sweden.
Rezeli M; Clinical Protein Science & Imaging, Department of Biomedical Engineering, BMC D13, Lund University, 22184, Lund, Sweden.; Swedish National Infrastructure for Biological Mass Spectrometry (BioMS), Lund University, 22184, Lund, Sweden.
Roybon L; iPSC Laboratory for CNS Disease Modelling, Department of Experimental Medical Science, BMC D10, Lund University, 22184, Lund, Sweden. .; Strategic Research Area MultiPark, Lund University, 22184, Lund, Sweden. .; Lund Stem Cell Center, Lund University, 22184, Lund, Sweden. .; Department of Neurodegenerative Science, The MiND Program, Van Andel Institute, Grand Rapids, MI, USA. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Sep 15; Vol. 11 (1), pp. 150. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*
Induced Pluripotent Stem Cells*
Animals ; Mice ; Humans ; Proteomics ; Autopsy ; Hippocampus
Czasopismo naukowe
Tytuł:
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol.
Autorzy:
Mazzeo S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy.; Research and Innovation Centre for Dementia-CRIDEM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Lassi M; The BioRobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant'Anna, Pisa, Italy.
Padiglioni S; Research and Innovation Centre for Dementia-CRIDEM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.; Regional Referral Centre for Relational Criticalities - Tuscany Region, Florence, Italy.
Vergani AA; The BioRobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant'Anna, Pisa, Italy.
Moschini V; Research and Innovation Centre for Dementia-CRIDEM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Scarpino M; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Giacomucci G; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy.
Burali R; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Morinelli C; Research and Innovation Centre for Dementia-CRIDEM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Fabbiani C; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Galdo G; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy.
Amato LG; The BioRobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant'Anna, Pisa, Italy.
Bagnoli S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy.
Emiliani F; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy.
Ingannato A; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy.
Nacmias B; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Grippo A; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Mazzoni A; The BioRobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant'Anna, Pisa, Italy.
Bessi V; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Largo Brambilla 3, Florence, 50134, Italy. .; Research and Innovation Centre for Dementia-CRIDEM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2023 Aug 12; Vol. 23 (1), pp. 300. Date of Electronic Publication: 2023 Aug 12.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/diagnosis
Alzheimer Disease*/genetics
Alzheimer Disease*/epidemiology
Cognitive Dysfunction*/epidemiology
Humans ; Prospective Studies ; Neuropsychological Tests ; Heterozygote ; Biomarkers ; Amyloid beta-Peptides
Czasopismo naukowe
Tytuł:
Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data.
Autorzy:
Conca F; IRCCS Mondino Foundation, Pavia, Italy.
Esposito V; IRCCS Mondino Foundation, Pavia, Italy.
Rundo F; Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy.
Quaranta D; Neurology Unit, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.; Department of Psychology, Catholic University of the Sacred Heart, Milan, Italy.
Muscio C; Present address: ASST Bergamo Ovest, Treviglio, Italy.; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Manenti R; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Caruso G; Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.
Lucca U; Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Galbussera AA; Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Di Tella S; IRCCS Fondazione Don Carlo Gnocchi, ONLUS, Milan, Italy.
Baglio F; IRCCS Fondazione Don Carlo Gnocchi, ONLUS, Milan, Italy.
L'Abbate F; Neurology Unit, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Canu E; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Catania V; Unit of Psychology I.C., Oasi Research Institute-IRCCS, Troina, Italy.
Filippi M; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Mattavelli G; IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy.; Istituti Clinici Scientifici Maugeri IRCCS, Cognitive Neuroscience Laboratory of Pavia Institute, Pavia, Italy.
Poletti B; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Silani V; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.; Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Università degli studi di Milano, Milan, Italy.
Lodi R; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
De Matteis M; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Stanzani Maserati M; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Arighi A; Fondazione IRCSS ca' Granda, Ospedale Policlinico, Milan, Italy.
Rotondo E; Fondazione IRCSS ca' Granda, Ospedale Policlinico, Milan, Italy.
Tanzilli A; Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Pace A; Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Garramone F; IRCCS Synlab SDN of Naples, Naples, Italy.
Cavaliere C; IRCCS Synlab SDN of Naples, Naples, Italy.
Pardini M; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy.
Rizzetto C; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy.
Sorbi S; IRCCS Fondazione Don Carlo Gnocchi, ONLUS, Milan, Italy.
Perri R; Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.
Tiraboschi P; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Canessa N; IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy.; Istituti Clinici Scientifici Maugeri IRCCS, Cognitive Neuroscience Laboratory of Pavia Institute, Pavia, Italy.
Cotelli M; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Ferri R; Department of Neurology IC, Oasi Research Institute - IRCCS, Troina, Italy.
Weintraub S; Mesulam Center for Cognitive Neurology and Alzheimer's Disease and Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Department of Neurology, Northwestern University, Chicago, IL, USA.
Marra C; Neurology Unit, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Tagliavini F; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Catricalà E; IRCCS Mondino Foundation, Pavia, Italy.; IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy.
Cappa SF; IRCCS Mondino Foundation, Pavia, Italy. .; IUSS Cognitive Neuroscience (ICON) Center, Scuola Universitaria Superiore IUSS, Palazzo del Broletto, Piazza Vittoria 15, 27100, Pavia, Italy. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2022 Aug 19; Vol. 14 (1), pp. 113. Date of Electronic Publication: 2022 Aug 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/diagnosis
Humans ; Italy ; Neuropsychological Tests
Czasopismo naukowe
Tytuł:
Gender differences in cognitive reserve: implication for subjective cognitive decline in women.
Autorzy:
Giacomucci G; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134, Florence, Italy.
Mazzeo S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Padiglioni S; Regional Referral Centre for Relational Criticalities - Tuscany Region, Florence, Italy.; Unit Clinic of Organizations Careggi University Hospital, Florence, Italy.
Bagnoli S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134, Florence, Italy.
Belloni L; Regional Referral Centre for Relational Criticalities - Tuscany Region, Florence, Italy.; Unit Clinic of Organizations Careggi University Hospital, Florence, Italy.
Ferrari C; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134, Florence, Italy.
Bracco L; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134, Florence, Italy.
Nacmias B; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Bessi V; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134, Florence, Italy. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Apr; Vol. 43 (4), pp. 2499-2508. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*
Cognitive Dysfunction*/epidemiology
Cognitive Dysfunction*/psychology
Cognitive Reserve*/physiology
Female ; Humans ; Male ; Neuropsychological Tests ; Sex Factors
Czasopismo naukowe
Tytuł:
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements.
Autorzy:
Nerattini M; Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Piero Palagi 1, 50139, Florence, Italy. .
Rubino F; Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Piero Palagi 1, 50139, Florence, Italy.
Arnone A; Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Piero Palagi 1, 50139, Florence, Italy.
Polito C; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence (NEUROFARBA), Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.
Mazzeo S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence (NEUROFARBA), Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.
Lombardi G; IRCCS Fondazione Don Carlo Gnocchi, Via Scandicci 269, 50143, Florence, Italy.
Puccini G; Department of Nuclear Medicine, Hospital of Prato, Via Suor Niccolina Infermiera, 20/22, 59100, Prato, Italy.
Nacmias B; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence (NEUROFARBA), Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Via Scandicci 269, 50143, Florence, Italy.
De Cristofaro MT; Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Piero Palagi 1, 50139, Florence, Italy.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence (NEUROFARBA), Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Via Scandicci 269, 50143, Florence, Italy.
Pupi A; Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Piero Palagi 1, 50139, Florence, Italy.
Sciagrà R; Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Piero Palagi 1, 50139, Florence, Italy.
Bessi V; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence (NEUROFARBA), Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.
Berti V; Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Piero Palagi 1, 50139, Florence, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Apr; Vol. 43 (4), pp. 2469-2480. Date of Electronic Publication: 2021 Nov 05.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/cerebrospinal fluid
Alzheimer Disease*/diagnostic imaging
Cognitive Dysfunction*/cerebrospinal fluid
Cognitive Dysfunction*/diagnostic imaging
Amyloid beta-Peptides/cerebrospinal fluid ; Biomarkers/cerebrospinal fluid ; Humans ; Peptide Fragments/cerebrospinal fluid ; Positron-Emission Tomography ; Retrospective Studies ; tau Proteins/cerebrospinal fluid
Czasopismo naukowe
Tytuł:
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain F-fluorodesoxyglucose-positron emission tomography.
Autorzy:
Cappelletto P; Department of Pediatric Neurology Unit and Laboratories, A. Meyer Children's Hospital, University of Florence, Florence, Italy.
Polito C; Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', Nuclear Medicine Unit, University of Florence, Florence, Italy.
Berti V; Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', Nuclear Medicine Unit, University of Florence, Florence, Italy.
Lombardi G; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Lucidi G; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Bessi V; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Sorbi S; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Ferrari C; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2021 Jul; Vol. 21 (4), pp. 514-520. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*
Problem Behavior*
Aged ; Brain ; Fluorodeoxyglucose F18 ; Humans ; Positron-Emission Tomography ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.
Autorzy:
Bessi V; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy. .
Mazzeo S; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Bagnoli S; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Padiglioni S; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Carraro M; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Piaceri I; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Bracco L; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Nacmias B; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi. Largo Brambilla, 3, 50134, Florence, Italy.
Pokaż więcej
Źródło:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2020 Jun; Vol. 270 (4), pp. 471-482. Date of Electronic Publication: 2019 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Disease Progression*
Alzheimer Disease/*genetics
Alzheimer Disease/*physiopathology
Brain-Derived Neurotrophic Factor/*genetics
Cognitive Dysfunction/*genetics
Cognitive Dysfunction/*physiopathology
Aged ; Aged, 80 and over ; Diagnostic Self Evaluation ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Polymorphism, Genetic
Czasopismo naukowe
Tytuł:
The diagnosis of dementias: a practical tool not to miss rare causes.
Autorzy:
Ferrari C; IRCCS Don Gnocchi, Via di Scandicci, Florence, Italy. .
Nacmias B; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy.
Sorbi S; IRCCS Don Gnocchi, Via di Scandicci, Florence, Italy.; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2018 Apr; Vol. 39 (4), pp. 615-627. Date of Electronic Publication: 2017 Dec 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease/*genetics
Brain/*pathology
Cognition Disorders/*genetics
Dementia, Vascular/*diagnosis
Alzheimer Disease/diagnosis ; Alzheimer Disease/pathology ; Atrophy/pathology ; Cognition Disorders/diagnosis ; Dementia, Vascular/genetics ; Dementia, Vascular/pathology ; Diagnosis, Differential ; Humans
Czasopismo naukowe
Tytuł:
Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.
Autorzy:
Berti V; Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', Nuclear Medicine Unit, University of Florence, Largo Brambilla 3, 50134, Florence, FI, Italy. .
Polito C; Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', Nuclear Medicine Unit, University of Florence, Largo Brambilla 3, 50134, Florence, FI, Italy.
Lombardi G; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Largo Brambilla 3, 50134, Florence, FI, Italy.
Ferrari C; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Largo Brambilla 3, 50134, Florence, FI, Italy.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Largo Brambilla 3, 50134, Florence, FI, Italy.
Pupi A; Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', Nuclear Medicine Unit, University of Florence, Largo Brambilla 3, 50134, Florence, FI, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2016 May; Vol. 37 (5), pp. 663-72. Date of Electronic Publication: 2016 Jan 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease/*cerebrospinal fluid
Alzheimer Disease/*diagnostic imaging
Biomarkers/*cerebrospinal fluid
Disease Progression ; Humans ; Neuroimaging
Czasopismo naukowe
Tytuł:
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Autorzy:
Escott-Price V; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Bellenguez C; Inserm U744, Lille, France; Université Lille 2, Lille, France; Institut Pasteur de Lille, Lille, France.
Wang LS; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Choi SH; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Harold D; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Jones L; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Holmans P; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Gerrish A; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Vedernikov A; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Richards A; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
DeStefano AL; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Lambert JC; Inserm U744, Lille, France; Université Lille 2, Lille, France; Institut Pasteur de Lille, Lille, France.
Ibrahim-Verbaas CA; Department of Epidemiology and Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Naj AC; Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Sims R; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Jun G; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America; Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Bis JC; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Beecham GW; The John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States of America; Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, United States of America.
Grenier-Boley B; Inserm U744, Lille, France; Université Lille 2, Lille, France; Institut Pasteur de Lille, Lille, France.
Russo G; Functional Genomics Center Zurich, ETH/University of Zurich, Zurich, Switzerland.
Thornton-Wells TA; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Denning N; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Smith AV; University of Iceland, Faculty of Medicine, Reykjavik, Iceland; Icelandic Heart Association, Kopavogur, Iceland.
Chouraki V; Inserm U744, Lille, France; Université Lille 2, Lille, France; Institut Pasteur de Lille, Lille, France; Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Thomas C; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Ikram MA; Departments of Epidemiology, Neurology and Radiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Aging, Leiden, The Netherlands.
Zelenika D; Centre National de Genotypage, Institut Genomique, Commissariat à l'énergie Atomique, Evry, France.
Vardarajan BN; Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts, United States of America; Taub Institute on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University New York, New York, United States of America; Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, New York, United States of America.
Kamatani Y; Fondation Jean Dausset- CEPH, Paris, France.
Lin CF; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Schmidt H; Institute for Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
Kunkle B; The John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States of America.
Dunstan ML; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Vronskaya M; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Johnson AD; NHLBI Cardiovascular Epidemiology and Human Genomics Branch, The Framingham Heart Study, Framingham, Massachusetts, United States of America.
Ruiz A; Memory Clinic of Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Spain.
Bihoreau MT; Centre National de Genotypage, Institut Genomique, Commissariat à l'énergie Atomique, Evry, France.
Reitz C; Taub Institute on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University New York, New York, United States of America; Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, New York, United States of America.
Pasquier F; Université Lille 2, Lille, France; CNR-MAJ, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Hollingworth P; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Hanon O; University Paris Descartes, Sorbonne Paris V, Broca Hospital, Geriatrics department, Paris, France.
Fitzpatrick AL; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, United States of America; Departments of Epidemiology and Global Health, University of Washington, Seattle, Washington, United States of America.
Buxbaum JD; Department of Neuroscience, Mount Sinai School of Medicine, New York, New York, United States of America; Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, United States of America; Departments of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, United States of America.
Campion D; CNR-MAJ, Inserm U1079, Rouen University Hospital, 76031 France, Rouen, France.
Crane PK; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Baldwin C; Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts, United States of America.
Becker T; German Center for Neurodegenerative Diseases (DZNE), Bonn, and Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.
Gudnason V; University of Iceland, Faculty of Medicine, Reykjavik, Iceland; Icelandic Heart Association, Kopavogur, Iceland.
Cruchaga C; Department of Psychiatry and Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Craig D; Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
Amin N; Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Berr C; INSERM U1061, Faculty of Medicine, Hôpital La Colombière, Montpellier, France.
Lopez OL; Departments of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
De Jager PL; Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Neurology & Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute, Boston, Massachusetts, United States of America.
Deramecourt V; Université Lille 2, Lille, France; CNR-MAJ, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Johnston JA; Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
Evans D; Rush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.
Lovestone S; King's College London, Institute of Psychiatry, Department of Neuroscience, De Crespigny Park, Denmark Hill, London, United Kingom.
Letenneur L; Inserm U897, Victor Segalen University, F-33076, Bordeaux, France.
Hernández I; Memory Clinic of Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Spain.
Rubinsztein DC; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Eiriksdottir G; Icelandic Heart Association, Kopavogur, Iceland.
Sleegers K; Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Goate AM; Department of Psychiatry and Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Fiévet N; Inserm U744, Lille, France; Institut Pasteur de Lille, Lille, France.
Huentelman MJ; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Gill M; Discipline of Psychiatry, Trinity College, Dublin, Ireland.
Brown K; Institute of Genetics, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Kamboh MI; Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Keller L; Aging Reasearch Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Barberger-Gateau P; King's College London, Institute of Psychiatry, Department of Neuroscience, De Crespigny Park, Denmark Hill, London, United Kingom.
McGuinness B; Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
Larson EB; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Group Health Research Institute, Group Health, Seattle, Washington, United States of America.
Myers AJ; Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
Dufouil C; Inserm U897, Victor Segalen University, F-33076, Bordeaux, France.
Todd S; Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
Wallon D; CNR-MAJ, Inserm U1079, Rouen University Hospital, 76031 France, Rouen, France.
Love S; University of Bristol Institute of Clinical Neurosciences, School of Clinical Sciences, Frenchay Hospital, Bristol, United Kingdom.
Rogaeva E; Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Ontario, Canada.
Gallacher J; Institute of Primary Care and Public Health, Cardiff University, Neuadd Meirionnydd, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.
George-Hyslop PS; Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Ontario, Canada; Cambridge Institute for Medical Research and Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Clarimon J; Neurology Department. IIB Sant Pau. Sant Pau Hospital. Universitat Autònoma de Barcelona, Barcelona, Spain; Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
Lleo A; Neurology Department. IIB Sant Pau. Sant Pau Hospital. Universitat Autònoma de Barcelona, Barcelona, Spain; Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
Bayer A; Institute of Primary Care and Public Health, Cardiff University, Neuadd Meirionnydd, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.
Tsuang DW; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, United States of America.
Yu L; Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, United States of America.
Tsolaki M; 3rd Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Bossù P; Clinical and Behavioral Neurology, Fondazione Santa Lucia, Roma, Italy.
Spalletta G; Clinical and Behavioral Neurology, Fondazione Santa Lucia, Roma, Italy.
Proitsi P; King's College London, Institute of Psychiatry, Department of Neuroscience, De Crespigny Park, Denmark Hill, London, United Kingom.
Collinge J; MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom.
Sorbi S; NEUROFARBA Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy; Centro di Ricerca, Trasferimento e Alta Formazione DENOTHE, University of Florence, Florence, Italy.
Garcia FS; Department of Immunology, Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Spain.
Fox NC; Dementia Research Center, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom.
Hardy J; Department of Molecular Neuroscience and Reta Lilla Weston Laboratories, Institute of Neurology, London, United Kingdom.
Naranjo MC; Department of Immunology, Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Spain.
Bosco P; IRCCS Associazione Oasi Maria SS, Troina, Italy.
Clarke R; Oxford Healthy Aging Project (OHAP), Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom.
Brayne C; Cognitive Function and Ageing Study (CFAS), Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.
Galimberti D; University of Milan, Fondazione Cà Granda, IRCCS Ospedale Policlinico, Milan, Italy.
Scarpini E; University of Milan, Fondazione Cà Granda, IRCCS Ospedale Policlinico, Milan, Italy.
Bonuccelli U; Neurological Clinic, University of Pisa, Pisa, Italy.
Mancuso M; Neurological Clinic, University of Pisa, Pisa, Italy.
Siciliano G; Neurological Clinic, University of Pisa, Pisa, Italy.
Moebus S; Urban Epidemiology, Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Mecocci P; Section of Gerontology and Geriatrics, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy.
Zompo MD; Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Maier W; Department of Psychiatry and Psychotherapy, University of Bonn, Germany and German Center for Neurodegenerative Diseases (DZNE, Bonn), Bonn, Germany.
Hampel H; Department of Psychiatry, University of Frankfurt am Main, Frankfurt am Main, Germany (H.H.); Department of Psychiatry, Ludwig-Maximilians University, Munich, Germany.
Pilotto A; Gerontology and Geriatrics Research Laboratory, I.R.C.C.S. Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy.
Frank-García A; Centro de Biología Molecular Severo Ochoa (CSIC-UAM); Madrid, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain; Instituto de Investigación Sanitaria 'Hospital la Paz' (IdIPaz), Madrid, Spain.
Panza F; Department of Geriatrics,Center for Aging Brain,University of Bari, Bari, Italy.
Solfrizzi V; Department of Geriatrics,Center for Aging Brain,University of Bari, Bari, Italy.
Caffarra P; Department of Neuroscience-University of Parma, Parma, Italy; Center for Cognitive Disorders AUSL, Parma, Italy.
Nacmias B; NEUROFARBA Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy; Centro di Ricerca, Trasferimento e Alta Formazione DENOTHE, University of Florence, Florence, Italy.
Perry W; The John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States of America; Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, United States of America.
Mayhaus M; Department Of Psychiatry, University Hospital, Saarland, Germany.
Lannfelt L; Department of Public Health/Geriatrics, Uppsala University, Uppsala, Sweden.
Hakonarson H; Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Pichler S; Department Of Psychiatry, University Hospital, Saarland, Germany.
Carrasquillo MM; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.
Ingelsson M; Department of Public Health/Geriatrics, Uppsala University, Uppsala, Sweden.
Beekly D; National Alzheimer's Coordinating Center, University of Washington, Seattle, Washington, United States of America.
Alvarez V; Genetica molecular-Huca-Oviedo, Oviedo, Spain.
Zou F; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.
Valladares O; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Younkin SG; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.
Coto E; Genetica molecular-Huca-Oviedo, Oviedo, Spain.
Hamilton-Nelson KL; The John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States of America.
Gu W; Department of Psychiatry, University Hospital, Saarland, Germany.
Razquin C; Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra School of Medicine, Pamplona, Spain.
Pastor P; Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra School of Medicine, Pamplona, Spain; CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
Mateo I; Neurology Service and CIBERNED, 'Marqués de Valdecilla' University Hospital (University of Cantabria and IFIMAV), Santander, Spain.
Owen MJ; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Faber KM; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, Indiana, United States of America.
Jonsson PV; University of Iceland, Faculty of Medicine, Reykjavik, Iceland; Landspitali University Hospital, Reykjavik, Iceland.
Combarros O; Neurology Service and CIBERNED, 'Marqués de Valdecilla' University Hospital (University of Cantabria and IFIMAV), Santander, Spain.
O'Donovan MC; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Cantwell LB; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Soininen H; Institute of Clinical Medicine - Neurology, University of Eastern Finland, Kuopio, Finland; Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
Blacker D; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, United States of America.
Mead S; MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom.
Mosley TH Jr; Department of Medicine (Geriatrics), University of Mississippi Medical Center, Jackson, Mississippi, United States of America.
Bennett DA; Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, United States of America; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, United States of America.
Harris TB; Laboratory of Epidemiology, Demography, and Biometry, National Institute of Health, Bethesda, Maryland, United States of America.
Fratiglioni L; Aging Research Center, Department Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden; Department Geriatric Medicine, Genetics Unit, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Holmes C; Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, United Kingdom.
de Bruijn RF; Departments of Neurology and Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Passmore P; Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
Montine TJ; Department of Pathology, University of Washington, Seattle, Washington, United States of America.
Bettens K; Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Rotter JI; Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States of America.
Brice A; INSERM UMR_S975-CNRS UMR 7225, Université Pierre et Marie Curie, Centre de recherche de l'Institut du Cerveau et de la Moëlle épinière-CRICM, Hôpital de la Salpêtrière, Paris France; AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.
Morgan K; Institute of Genetics, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Foroud TM; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, Indiana, United States of America.
Kukull WA; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Hannequin D; CNR-MAJ, Inserm U1079, Rouen University Hospital, 76031 France, Rouen, France.
Powell JF; King's College London, Institute of Psychiatry, Department of Neuroscience, De Crespigny Park, Denmark Hill, London, United Kingom.
Nalls MA; Laboratory of Neurogenetics, Intramural Research Program, National Institute on Aging, Bethesda, Maryland, United States of America.
Ritchie K; INSERM U1061, Faculty of Medicine, Hôpital La Colombière, Montpellier, France; Imperial College, London, United Kingdom.
Lunetta KL; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Kauwe JS; Department of Biology, Brigham Young University, Provo, Utah, United States of America.
Boerwinkle E; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States of America; Human Genetics Center and Div. of Epidemiology, University of Texas Health Sciences Center at Houston, Houston, Texas, United States of America.
Riemenschneider M; Department of Psychiatry, University Hospital, Saarland, Germany.
Boada M; Memory Clinic of Fundació ACE. Institut Català de Neurociències Aplicades, Barcelona, Spain; Hospital Universitari Vall d'Hebron - Institut de Recerca, Universitat Autònoma de Barcelona. (VHIR-UAB), Barcelona, Spain.
Hiltunen M; Institute of Clinical Medicine - Neurology, University of Eastern Finland, Kuopio, Finland; Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
Martin ER; The John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States of America; Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, United States of America.
Schmidt R; Department of Neurology, Medical University Graz, Graz, Austria.
Rujescu D; Department of Psychiatry, Ludwig-Maximilians University, Munich, Germany.
Dartigues JF; Inserm U897, Victor Segalen University, F-33076, Bordeaux, France; Centre de Mémoire de Ressources et de Recherche de Bordeaux, CHU de Bordeaux, Bordeaux, France.
Mayeux R; Taub Institute on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University New York, New York, United States of America; Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, New York, United States of America.
Tzourio C; Inserm U708, Victor Segalen University, Bordeaux, France.
Hofman A; Departments of Epidemiology, Neurology and Radiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Aging, Leiden, The Netherlands.
Nöthen MM; Institute of Human Genetics, Department of Genomics, Life and Brain Center, University of Bonn, and German Center for Neurodegenerative Diseases (DZNE, Bonn), Bonn, Germany.
Graff C; Department Geriatric Medicine, Genetics Unit, Karolinska University Hospital Huddinge, Stockholm, Sweden; Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, KIADRC, Stockholm, Sweden.
Psaty BM; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, United States of America; Group Health Research Institute, Group Health Cooperative, Seattle, Washington, United States of America.
Haines JL; Vanderbilt Center for Human Genetics Research, Vanderbilt University, Nashville, Tennessee, United States of America; Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, Ohio, United States of America.
Lathrop M; Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, United States of America; Fondation Jean Dausset- CEPH, Paris, France; McGill University and Génome Québec Innovation Centre, Montreal, Canada.
Pericak-Vance MA; The John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States of America; Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida, United States of America.
Launer LJ; Laboratory of Epidemiology, Demography, and Biometry, National Institute of Health, Bethesda, Maryland, United States of America.
Van Broeckhoven C; Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Farrer LA; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America; Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America; Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
van Duijn CM; Netherlands Consortium for Healthy Aging, Leiden, The Netherlands; Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands; Center for Medical Systems Biology, Leiden, The Netherlands.
Ramirez A; Department of Psychiatry and Psychotherapy and Institute of Human Genetics, University of Bonn, Bonn, Germany.
Seshadri S; Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, United States of America; The Framingham Heart Study, Framingham, Massachusetts, United States of America.
Schellenberg GD; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Amouyel P; Inserm U744, Lille, France; Université Lille 2, Lille, France; Institut Pasteur de Lille, Lille, France; CNR-MAJ, Centre Hospitalier Régional Universitaire de Lille, Lille, France; Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Williams J; Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
Pokaż więcej
Corporate Authors:
United Kingdom Brain Expression Consortium
Cardiovascular Health Study (CHS)
Źródło:
PloS one [PLoS One] 2014 Jun 12; Vol. 9 (6), pp. e94661. Date of Electronic Publication: 2014 Jun 12 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Alzheimer Disease/*genetics
Carrier Proteins/*genetics
Heat-Shock Proteins/*genetics
Case-Control Studies ; Genome-Wide Association Study ; Humans ; Polymorphism, Single Nucleotide ; Receptors, Antigen, B-Cell/genetics
Czasopismo naukowe
Tytuł:
Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study.
Autorzy:
Spalletta G; Neuropsychiatry Laboratory, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.
Caltagirone C; Neuropsychiatry Laboratory, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy ; Department of System Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Padovani A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Sorbi S; Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy.
Attar M; Novartis Farma Italia, Origgio (Varese), Italy.
Colombo D; Novartis Farma Italia, Origgio (Varese), Italy.
Cravello L; Neuropsychiatry Laboratory, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.
Pokaż więcej
Corporate Authors:
E V O L U T I O N study Working Group
Źródło:
PloS one [PLoS One] 2014 Feb 19; Vol. 9 (2), pp. e89216. Date of Electronic Publication: 2014 Feb 19 (Print Publication: 2014).
Typ publikacji:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*drug therapy
Alzheimer Disease/*physiopathology
Cholinesterase Inhibitors/*therapeutic use
Cognitive Dysfunction/*physiopathology
Mood Disorders/*physiopathology
Apathy/drug effects ; Apathy/physiology ; Depression/physiopathology ; Drug Substitution ; Humans ; Italy ; Phenylcarbamates/therapeutic use ; Rivastigmine ; Socioeconomic Factors
Czasopismo naukowe
Tytuł:
A pilot study evaluating the contribution of SLC19A1 (RFC-1) 80G>a polymorphism to Alzheimer's disease in Italian Caucasians.
Autorzy:
Coppedè F; Division of Medical Genetics, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Medical School, Via Roma 56, 56126 Pisa, Italy.
Tannorella P; Division of Medical Genetics, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Medical School, Via Roma 56, 56126 Pisa, Italy.
Tognoni G; Unit of Neurology, Department of Neuroscience, Pisa University Hospital, Via Roma 67, 56126 Pisa, Italy.
Bagnoli S; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Bongioanni P; Unit of Neurorehabilitation, Department of Neuroscience, Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy.
Nacmias B; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Siciliano G; Unit of Neurology, Department of Neuroscience, Pisa University Hospital, Via Roma 67, 56126 Pisa, Italy ; Department of Clinical and Experimental Medicine, University of Pisa, Neurological Clinic, Via Roma 67, 56126 Pisa, Italy.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Bonuccelli U; Unit of Neurology, Department of Neuroscience, Pisa University Hospital, Via Roma 67, 56126 Pisa, Italy ; Department of Clinical and Experimental Medicine, University of Pisa, Neurological Clinic, Via Roma 67, 56126 Pisa, Italy.
Migliore L; Division of Medical Genetics, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Medical School, Via Roma 56, 56126 Pisa, Italy.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2014; Vol. 2014, pp. 608104. Date of Electronic Publication: 2014 Jun 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Association Studies*
Alzheimer Disease/*genetics
Reduced Folate Carrier Protein/*genetics
Aged ; Aged, 80 and over ; Alzheimer Disease/pathology ; Female ; Genotype ; Humans ; Male ; Polymorphism, Single Nucleotide ; Risk Factors
Czasopismo naukowe
Tytuł:
TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
Autorzy:
Bagnoli S; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. />Piaceri I
Tedde A
Bessi V
Bracco L
Sorbi S
Nacmias B
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2013 Jun; Vol. 34 (6), pp. 995-8. Date of Electronic Publication: 2013 Apr 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*genetics
Frontotemporal Dementia/*genetics
Genetic Predisposition to Disease/*genetics
Membrane Transport Proteins/*genetics
Polymorphism, Single Nucleotide/*genetics
Aged ; Aged, 80 and over ; Apolipoproteins E/genetics ; Female ; Gene Frequency ; Genetic Association Studies ; Genotype ; Humans ; Italy ; Male ; Mitochondrial Precursor Protein Import Complex Proteins
Czasopismo naukowe
Tytuł:
Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease.
Autorzy:
Musicco M; Institute of Biomedical Technologies, National Research Council, Segrate (Mi), Foundation IRCCS 'Santa Lucia', Rome, Italy.
Padovani A
Sorbi S
Scarpini E
Caffarra P
Cappa S
Clerici F
Tabaton M
Caltagirone C
Bonavita V
Bruni AC
Bruno G
Federico A
Ferrarese C
Marra C
Nacmias B
Parnetti L
Pettenati C
Sorrentino G
Tagliavini F
Mariani C
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2012 Feb; Vol. 33 (1), pp. 201-8. Date of Electronic Publication: 2011 Nov 05.
Typ publikacji:
Consensus Development Conference; Journal Article
MeSH Terms:
Alzheimer Disease/*diagnosis
Dementia/*diagnosis
Diagnosis, Differential ; Humans
Czasopismo naukowe
Tytuł:
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Autorzy:
Hollingworth P; Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Neurosciences and Mental Health Research Institute, Department of Psychological Medicine and Neurology, School of Medicine, Cardiff University, Cardiff, UK.
Harold D
Sims R
Gerrish A
Lambert JC
Carrasquillo MM
Abraham R
Hamshere ML
Pahwa JS
Moskvina V
Dowzell K
Jones N
Stretton A
Thomas C
Richards A
Ivanov D
Widdowson C
Chapman J
Lovestone S
Powell J
Proitsi P
Lupton MK
Brayne C
Rubinsztein DC
Gill M
Lawlor B
Lynch A
Brown KS
Passmore PA
Craig D
McGuinness B
Todd S
Holmes C
Mann D
Smith AD
Beaumont H
Warden D
Wilcock G
Love S
Kehoe PG
Hooper NM
Vardy ER
Hardy J
Mead S
Fox NC
Rossor M
Collinge J
Maier W
Jessen F
Rüther E
Schürmann B
Heun R
Kölsch H
van den Bussche H
Heuser I
Kornhuber J
Wiltfang J
Dichgans M
Frölich L
Hampel H
Gallacher J
Hüll M
Rujescu D
Giegling I
Goate AM
Kauwe JS
Cruchaga C
Nowotny P
Morris JC
Mayo K
Sleegers K
Bettens K
Engelborghs S
De Deyn PP
Van Broeckhoven C
Livingston G
Bass NJ
Gurling H
McQuillin A
Gwilliam R
Deloukas P
Al-Chalabi A
Shaw CE
Tsolaki M
Singleton AB
Guerreiro R
Mühleisen TW
Nöthen MM
Moebus S
Jöckel KH
Klopp N
Wichmann HE
Pankratz VS
Sando SB
Aasly JO
Barcikowska M
Wszolek ZK
Dickson DW
Graff-Radford NR
Petersen RC
van Duijn CM
Breteler MM
Ikram MA
DeStefano AL
Fitzpatrick AL
Lopez O
Launer LJ
Seshadri S
Berr C
Campion D
Epelbaum J
Dartigues JF
Tzourio C
Alpérovitch A
Lathrop M
Feulner TM
Friedrich P
Riehle C
Krawczak M
Schreiber S
Mayhaus M
Nicolhaus S
Wagenpfeil S
Steinberg S
Stefansson H
Stefansson K
Snaedal J
Björnsson S
Jonsson PV
Chouraki V
Genier-Boley B
Hiltunen M
Soininen H
Combarros O
Zelenika D
Delepine M
Bullido MJ
Pasquier F
Mateo I
Frank-Garcia A
Porcellini E
Hanon O
Coto E
Alvarez V
Bosco P
Siciliano G
Mancuso M
Panza F
Solfrizzi V
Nacmias B
Sorbi S
Bossù P
Piccardi P
Arosio B
Annoni G
Seripa D
Pilotto A
Scarpini E
Galimberti D
Brice A
Hannequin D
Licastro F
Jones L
Holmans PA
Jonsson T
Riemenschneider M
Morgan K
Younkin SG
Owen MJ
O'Donovan M
Amouyel P
Williams J
Pokaż więcej
Corporate Authors:
Alzheimer's Disease Neuroimaging Initiative
CHARGE consortium
EADI1 consortium
Źródło:
Nature genetics [Nat Genet] 2011 May; Vol. 43 (5), pp. 429-35. Date of Electronic Publication: 2011 Apr 03.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
ATP-Binding Cassette Transporters/*genetics
Adaptor Proteins, Signal Transducing/*genetics
Alzheimer Disease/*genetics
Antigens, CD/*genetics
Antigens, Differentiation, Myelomonocytic/*genetics
Cytoskeletal Proteins/*genetics
Membrane Proteins/*genetics
Receptor, EphA1/*genetics
Aged ; Aged, 80 and over ; Case-Control Studies ; Databases, Genetic ; Female ; Genetic Predisposition to Disease ; Genetic Variation ; Genome-Wide Association Study ; Humans ; Male ; Multigene Family ; Polymorphism, Single Nucleotide ; Sialic Acid Binding Ig-like Lectin 3
Czasopismo naukowe
Tytuł:
Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians.
Autorzy:
Piaceri I; Department of Neurological and Psychiatric Sciences, University of Florence and Centro di Ricerca,Trasferimento e Alta Formazione DENOTHE, University of Florence, Viale Morgagni, Firenze, Italy.
Bagnoli S
Lucenteforte E
Mancuso M
Tedde A
Siciliano G
Piacentini S
Bracco L
Sorbi S
Nacmias B
Pokaż więcej
Źródło:
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2011; Vol. 24 (3), pp. 409-13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aged, 80 and over*
Genetic Predisposition to Disease*
Alzheimer Disease/*genetics
Monomeric Clathrin Assembly Proteins/*genetics
Aged ; Female ; Gene Frequency ; Genome-Wide Association Study ; Genotype ; Humans ; Italy ; Male
Czasopismo naukowe
Tytuł:
Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease.
Autorzy:
Santoro A; Department of Experimental Pathology, University of Bologna, Bologna, Italy. />Balbi V
Balducci E
Pirazzini C
Rosini F
Tavano F
Achilli A
Siviero P
Minicuci N
Bellavista E
Mishto M
Salvioli S
Marchegiani F
Cardelli M
Olivieri F
Nacmias B
Chiamenti AM
Benussi L
Ghidoni R
Rose G
Gabelli C
Binetti G
Sorbi S
Crepaldi G
Passarino G
Torroni A
Franceschi C
Pokaż więcej
Źródło:
PloS one [PLoS One] 2010 Aug 06; Vol. 5 (8), pp. e12037. Date of Electronic Publication: 2010 Aug 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Predisposition to Disease*
Alzheimer Disease/*genetics
DNA, Mitochondrial/*genetics
Haplotypes/*genetics
Aged ; Case-Control Studies ; Female ; Humans ; Mutation ; Phylogeny ; Polymorphism, Genetic
Czasopismo naukowe
Tytuł:
Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patients.
Autorzy:
Lescai F; Division of Research Strategy, University College London, London, UK. />Pirazzini C
D'Agostino G
Santoro A
Ghidoni R
Benussi L
Galimberti D
Federica E
Marchegiani F
Cardelli M
Olivieri F
Nacmias B
Sorbi S
Bagnoli S
Tagliavini F
Albani D
Martinelli Boneschi F
Binetti G
Forloni G
Quadri P
Scarpini E
Franceschi C
Pokaż więcej
Źródło:
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2010; Vol. 21 (2), pp. 385-8.
Typ publikacji:
Journal Article
MeSH Terms:
Polymorphism, Single Nucleotide*
Alzheimer Disease/*genetics
Cadherins/*genetics
Aged ; Apolipoprotein E4/genetics ; Female ; Genome-Wide Association Study ; Genotype ; Humans ; Italy ; Logistic Models ; Male ; Middle Aged ; Protocadherins ; White People/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies